Epigral Ltd Stock Price Today (NSE: EPIGRAL)
Fundamental Score
Epigral Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Epigral Ltd share price today is ₹810.45, down 5.15% on NSE/BSE as of 30 March 2026. Epigral Ltd (EPIGRAL) is a Mid-cap company in the Specialty Chemicals sector with a market capitalisation of ₹6.47K (Cr). The 52-week high for EPIGRAL share price is ₹2114.00 and the 52-week low is ₹811.70. At a P/E ratio of 16.09x, EPIGRAL is currently trading below its industry average P/E of 29.20x. The company has a Return on Equity (ROE) of 22.30% and a debt-to-equity ratio of 0.26.
Epigral Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Epigral Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Epigral Share Price: A Growth Strategist's Perspective
The specialty chemicals sector is currently witnessing a surge in demand, driven by increased consumption in end-user industries and a growing emphasis on domestic manufacturing. Analyzing the **Epigral share price**, currently trading at ₹991.90, requires a deep dive into its financial health and competitive positioning. This analysis forms part of a comprehensive 80-parameter fundamental audit, verified by Sweta Mishra, providing an objective assessment of the company’s strengths and weaknesses.
Epigral's current Price-to-Earnings (PE) ratio of 16.09 warrants a comparison with its peers. While a definitive judgment on undervaluation or overvaluation necessitates a more granular analysis, initial observation suggests that the market is assigning a reasonable multiple to its earnings, in-line with specialty chemical firms that present growth potential. Comparing Epigral Ltd with peers like
Amal regarding management quality, investor sentiment appears cautiously optimistic, although more detailed information is needed to fully understand the quality of its managerial capabilities.A particularly noteworthy metric is Epigral's Return on Capital Employed (ROCE) of 24.88%. This high ROCE is potentially a critical factor reinforcing the company's economic moat. A higher ROCE suggests that Epigral is efficiently deploying capital and generating superior returns compared to its cost of capital, giving it a competitive advantage and stronger ability to reinvest in growth, new technologies, or acquisitions. This efficiency helps insulate it from some competitive pressures. The peers Amal, Bhatia Colour, and Deep Polymers would need a ROCE comparison for benchmarking.
Ultimately, understanding the long-term potential of the Epigral share price requires continuous monitoring of its financial performance, its strategic initiatives, and the evolving dynamics of the specialty chemicals industry. This initial overview provides a foundation for a more in-depth investment thesis, one that further explores the drivers of its high ROCE and its ability to sustain this performance in the face of competition.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Epigral Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of EPIGRAL across key market metrics for learning purposes.
Positive Indicators
12 factors identified
Strong Return on Equity (22.30%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (24.88%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Strong Operating Margins (29.31%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Attractive Valuation (P/E: 16.09 vs Industry: 29.20)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Consistent Growth Track Record (33.10% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Excellent EPS Growth (24.65% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (25.81% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Conservative Debt Levels (D/E: 0.26)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (9.11x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Strong Cash Generation (₹323.16 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Balanced Promoter Holding (68.83%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
3 factors identified
Profit Decline Concern (-36.02%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Revenue Contraction (-6.18%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Limited Institutional Interest (FII+DII: 7.64%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
Epigral Ltd Financial Statements
Comprehensive financial data for Epigral Ltd including income statement, balance sheet and cash flow
About EPIGRAL (Epigral Ltd)
Epigral Ltd is a dynamic force in the specialty chemicals arena, carving a niche for itself through innovative manufacturing and a commitment to global reach. The company stands as... a vertically integrated entity, mastering the complexities of the chlor-alkali process to produce a diverse range of high-value derivatives. More than just a manufacturer, Epigral is a creator of essential building blocks for a multitude of industries, transforming raw materials into specialized compounds that fuel progress and enable advanced applications. Epigral's unwavering focus on quality, safety, and sustainability ensures that its products not only meet but exceed industry standards, establishing it as a trusted partner in a competitive market. At the heart of Epigral's operations lies a dedication to harnessing the power of chlorine and its derivatives. From the resilient chlorinated polyvinyl chloride (CPVC) resins and compounds that fortify infrastructure to the reactive epichlorohydrin that forms the basis of countless epoxy resins, Epigral's product portfolio is both diverse and strategically focused. The company also demonstrates expertise in the chloromethanes value chain and produces hydrogen peroxide, caustic soda and potash, chlorine and hydrogen, offering a comprehensive suite of chemicals indispensable to various industrial processes. Epigral's commitment to self-sufficiency is evident in its captive power plant (CPP) and chlorotoluene value chain and its strategic investments in renewable energy through wind-solar hybrid power plants. Epigral's impact resonates across a broad spectrum of applications. Its CPVC resins and compounds are pivotal in the manufacturing of robust CPVC pipes and fittings, ensuring reliable fluid transport. Furthermore, its chemical solutions find application in diverse sectors, including windmills, construction, paints, and pharmaceuticals, solidifying Epigral's position as a key supplier in the global market. Through continuous innovation and a customer-centric approach, Epigral is dedicated to providing solutions that drive efficiency, enhance performance, and contribute to a more sustainable future for its partners and the planet.
Company Details
Key Leadership
Corporate Events
EPIGRAL Share Price: Frequently Asked Questions
What is the current share price of Epigral Ltd (EPIGRAL)?
As of 30 Mar 2026, 12:02 pm IST, Epigral Ltd share price is ₹810.45. The EPIGRAL stock has a market capitalisation of ₹6.47K (Cr) on NSE/BSE.
Is EPIGRAL share price Overvalued or Undervalued?
EPIGRAL share price is currently trading at a P/E ratio of 16.09x, compared to the industry average of 29.20x. Based on this relative valuation, the Epigral Ltd stock appears to be Undervalued against its sector peers.
What is the 52-week high and low of EPIGRAL share price?
The 52-week high of EPIGRAL share price is ₹2114.00 and the 52-week low is ₹811.70. These values are updated daily from NSE/BSE price data.
What factors affect the Epigral Ltd share price?
Key factors influencing EPIGRAL share price include quarterly earnings growth (Sales Growth: -6.18%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Epigral Ltd a good stock for long-term investment?
Epigral Ltd shows a 5-year Profit Growth of 25.81% and an ROE of 22.30%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.26 before investing in EPIGRAL shares.
How does Epigral Ltd compare with its industry peers?
Epigral Ltd competes with major peers in the Specialty Chemicals. Investors should compare EPIGRAL share price P/E of 16.09x and ROE of 22.30% against the industry averages to determine competitive standing.
What is the P/E ratio of EPIGRAL and what does it mean?
EPIGRAL share price has a P/E ratio of 16.09x compared to the industry average of 29.20x. Investors pay ₹16 for every ₹1 of annual earnings.
How is EPIGRAL performing according to Bull Run's analysis?
EPIGRAL has a Bull Run fundamental score of 64.9/100, indicating moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does EPIGRAL belong to?
EPIGRAL operates in the Specialty Chemicals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Epigral Ltd share price.
What is Return on Equity (ROE) and why is it important for EPIGRAL?
EPIGRAL has an ROE of 22.30%, which indicates excellent management efficiency. ROE measures how efficiently Epigral Ltd generates profits from shareholders capital.
How is EPIGRAL debt-to-equity ratio and what does it indicate?
EPIGRAL has a debt-to-equity ratio of 0.26, which indicates conservative financing with low financial risk.
What is EPIGRAL dividend yield and is it a good dividend stock?
EPIGRAL offers a dividend yield of 0.40%, meaning you receive ₹0.40 annual dividend for every ₹100 invested in Epigral Ltd shares.
How has EPIGRAL share price grown over the past 5 years?
EPIGRAL has achieved 5-year growth rates of: Sales Growth 33.10%, Profit Growth 25.81%, and EPS Growth 24.65%.
What is the promoter holding in EPIGRAL and why does it matter?
Promoters hold 68.83% of EPIGRAL shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Epigral Ltd.
What is EPIGRAL market capitalisation category?
EPIGRAL has a market capitalisation of ₹6471 crores, placing it in the Mid-cap category.
How volatile is EPIGRAL stock?
EPIGRAL has a beta of N/A. A beta > 1 suggests the Epigral Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is EPIGRAL operating profit margin trend?
EPIGRAL has a 5-year average Operating Profit Margin (OPM) of 29.31%, indicating the company's operational efficiency.
How is EPIGRAL quarterly performance?
Recent quarterly performance shows Epigral Ltd YoY Sales Growth of -6.18% and YoY Profit Growth of -36.02%.
What is the institutional holding pattern in EPIGRAL?
EPIGRAL has FII holding of 2.71% and DII holding of 4.93%. Significant institutional holding often suggests professional confidence in the Epigral Ltd stock.